UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000020286
Receipt No. R000023423
Official scientific title of the study Evaluation of drug interactions of cytochrome P450 by single-substrate administrations and the cocktail method
Date of disclosure of the study information 2015/12/21
Last modified on 2016/12/20 (Ver. 12)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of drug interactions of cytochrome P450 by single-substrate administrations and the cocktail method
Title of the study (Brief title) Evaluation of drug interactions of cytochrome P450 by single-substrate administrations and the cocktail method
Region
Japan

Condition
Condition drug interaction
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to clarify the changes of cytochrome P450
(CYP) activities (1A2, 2C9, 2C19, 2D6) evaluated between single-probe administrations and cocktail method after administrations of a CYP-inducer and CYP inhibitors.
Basic objectives2 Pharmacokinetics
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Pharmacokinetics of caffeine, losartan omeprazole, dextromethorphan
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 drugs(CYP inducer and inhibitor)

inducer : rifampicin 450 mg s.i.d for 6 days before trial

inhibitor : cimetidine 400mg b.i.d for 2 days before trial, fluvoxamine 25 mg b.i.d for 2days before trial
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria 1 helthy male, over 20 years old
2 without hepatic disorder, renal disorder and disease under treatment
3 without medication allergy and idiosyncrasy
4 without drug dependence and alchol dependence
5 with consent to take part in this study by document
Key exclusion criteria 1 being unwellness
2 with abnormalities of bllod examination in advance
3 inadequateness to this study
Target sample size 24

Research contact person
Name of lead principal investigator Hiroshi Watanabe
Organization Hamamatsu University School of Medicine
Division name Department of Clinical Pharmacology and Therapetics
Address 1-20-1, Hanadayama, Higashi-ku, Hamamatsu
TEL 053-435-2385
Email hwat@hama-med.ac.jp

Public contact
Name of contact person Akio Hakamata
Organization Hamamatsu University School of Medicine
Division name Department of Clinical Pharmacology and Therapetics
Address 1-20-1, Hanadayama, Higashi-ku, Hamamatsu
TEL 053-435-2385
Homepage URL
Email hakamata@hama-med.ac.jp

Sponsor
Institute Hamamatsu University School of Medicine
Institute
Department

Funding Source
Organization Ministry of Education, Sports, Science, and Technology
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor Department of Parmacy Practice and Science, School of PharmaceuticalaScience, University of Shizuoka
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 21 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2015 Year 11 Month 12 Day
Anticipated trial start date
2015 Year 12 Month 21 Day
Last follow-up date
2017 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 21 Day
Last modified on
2016 Year 12 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023423